Phase Ib II

Advertisement

cGxPJobs Banner

Boehringer Ingelheim, Zai Lab Advance DLL3 Cancer Trial

Ingelheim, Germany & Shanghai, China | April 15, 2026 Boehringer Ingelheim and Zai Lab have announced a strategic clinical...

By cGxPwire Editor
April 16, 2026

Read More

Advertisement

cGxPJobs

Directory